It’s not surprising that the nursing home industry is filing lawsuits to block new Biden administration rules requiring minimum staffing at facilities that accept federal dollars.
AlloVir lays off 95% of staffers after shuttering PhIII antiviral cell therapy trials
AlloVir is laying off 95% of its workers to “reduce costs and preserve capital” after discontinuing three Phase III trials of its antiviral cell therapy